With the deepening of China’s health care reform, the growing awareness of people’s health and the improvement of detection technologies, the Chinese market will further accelerate the pace of expansion.
According to the latest “2013-2015 Chinese Diagnostic Reagent Market Report†released by ChinaMarket Research Reports, Chinese local diagnostic reagent companies are gradually breaking the monopoly of foreign brands.
In China, in vitro diagnostic reagents include biochemical diagnostic reagents, immunodiagnostic reagents, molecular diagnostic reagents, and blood diagnostic reagents. In 2012, China's biochemical and immunodiagnostic reagents reached the highest market share of 70%, which is determined by domestic medical demand. The Chinese economy and the government’s medical expenses are still at a low level, which has a great impact on the medical diagnosis and consumption.
In the next three years, China will have the largest demand for routine testing. In China, advances in diagnostic technology and the increase in high-end consumers will drive the market demand for molecular diagnostic reagents and other related reagents. It is predicted that the demand for biochemical and immunodiagnostic reagents will drop to 60% in 2015. With cost-effective and local advantages, China's diagnostic reagent companies can break the monopoly of foreign brands.
However, foreign companies still hold a 30-40% share of the Chinese market, showing obvious technical advantages in the mid-to-high end areas, as well as a monopoly on the "instrument reagent" integration platform.
It is understood that the "2014 Advanced In Vitro Diagnostic Technology Summit" held in Shanghai on February 20th, 2014 will carry out in-depth discussion on the above-mentioned focus of attention. The event will invite experts from a variety of industry sectors to give speeches at the conference, centering on “How to Grasp the Advanced Biotechnology in a Timely Way†and “If Advanced Technology Is Used to Develop New In Vitro Diagnostic Productsâ€, “How do domestic diagnostic companies find new breakthroughsâ€? Whether transnational project cooperation can enter deeper stages, such as "How reagent science research can be integrated into the integration of production, education and research," and other hot issues can be deeply interpreted and fully explained.
According to the latest “2013-2015 Chinese Diagnostic Reagent Market Report†released by ChinaMarket Research Reports, Chinese local diagnostic reagent companies are gradually breaking the monopoly of foreign brands.
In China, in vitro diagnostic reagents include biochemical diagnostic reagents, immunodiagnostic reagents, molecular diagnostic reagents, and blood diagnostic reagents. In 2012, China's biochemical and immunodiagnostic reagents reached the highest market share of 70%, which is determined by domestic medical demand. The Chinese economy and the government’s medical expenses are still at a low level, which has a great impact on the medical diagnosis and consumption.
In the next three years, China will have the largest demand for routine testing. In China, advances in diagnostic technology and the increase in high-end consumers will drive the market demand for molecular diagnostic reagents and other related reagents. It is predicted that the demand for biochemical and immunodiagnostic reagents will drop to 60% in 2015. With cost-effective and local advantages, China's diagnostic reagent companies can break the monopoly of foreign brands.
However, foreign companies still hold a 30-40% share of the Chinese market, showing obvious technical advantages in the mid-to-high end areas, as well as a monopoly on the "instrument reagent" integration platform.
It is understood that the "2014 Advanced In Vitro Diagnostic Technology Summit" held in Shanghai on February 20th, 2014 will carry out in-depth discussion on the above-mentioned focus of attention. The event will invite experts from a variety of industry sectors to give speeches at the conference, centering on “How to Grasp the Advanced Biotechnology in a Timely Way†and “If Advanced Technology Is Used to Develop New In Vitro Diagnostic Productsâ€, “How do domestic diagnostic companies find new breakthroughsâ€? Whether transnational project cooperation can enter deeper stages, such as "How reagent science research can be integrated into the integration of production, education and research," and other hot issues can be deeply interpreted and fully explained.
Camera Monitor System, Electronic rearview mirror, Car Electronic Rearview Mirror
Shenzhen Zhitong Yingchuang Electronic Technology Co., Ltd. , https://www.visualdriving.com